Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rikke Fredslund Andersen

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Expert Review of Molecular Diagnostics|November 10, 2018
Tumor-specific methylations in circulating cell-free DNA as clinically applicable markers with potential to substitute mutational analysesRikke Fredslund Andersen
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 17, 2016
Screening for circulating RAS/RAF mutations by multiplex digital PCRRikke Fredslund Andersen, Anders Jakobsen
Methods in Molecular Biology (Clifton, N.J.)|October 10, 2025
Digital PCR Analysis of Methylated Circulating Tumor DNARikke Fredslund Andersen, Tina Brandt Christensen, Torben Frøstrup Hansen
International Journal of Cancer|March 25, 2014
Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasmaKaren-Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, et al.
Biotechniques|May 4, 2026
Evaluation and verification of cfDNA extraction methodsCecilie Mondrup Jacobsen, Luisa Matos do Canto, Estrid Høgdall, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Improved sensitivity of circulating tumor DNA measurement using short PCR ampliconsRikke Fredslund Andersen, Karen-Lise Garm Spindler, Ivan Brandslund, et al.
Plos One|April 16, 2015
Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancerKaren Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2015
Controls to validate plasma samples for cell free DNA quantificationNiels Pallisgaard, Karen-Lise Garm Spindler, Rikke Fredslund Andersen, et al.
Pharmacological Research|January 15, 2019
Delta tocotrienol in recurrent ovarian cancer. A phase II trialCaroline Brenner Thomsen, Rikke Fredslund Andersen, Karina Dahl Steffensen, et al.
Scientific Reports|May 26, 2017
Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumabTorben Frøstrup Hansen, Rikke Fredslund Andersen, Dorte Aalund Olsen, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Expert Review of Molecular Diagnostics|November 10, 2018
Tumor-specific methylations in circulating cell-free DNA as clinically applicable markers with potential to substitute mutational analysesRikke Fredslund Andersen
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 17, 2016
Screening for circulating RAS/RAF mutations by multiplex digital PCRRikke Fredslund Andersen, Anders Jakobsen
Methods in Molecular Biology (Clifton, N.J.)|October 10, 2025
Digital PCR Analysis of Methylated Circulating Tumor DNARikke Fredslund Andersen, Tina Brandt Christensen, Torben Frøstrup Hansen
International Journal of Cancer|March 25, 2014
Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasmaKaren-Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, et al.
Biotechniques|May 4, 2026
Evaluation and verification of cfDNA extraction methodsCecilie Mondrup Jacobsen, Luisa Matos do Canto, Estrid Høgdall, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Improved sensitivity of circulating tumor DNA measurement using short PCR ampliconsRikke Fredslund Andersen, Karen-Lise Garm Spindler, Ivan Brandslund, et al.
Plos One|April 16, 2015
Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancerKaren Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2015
Controls to validate plasma samples for cell free DNA quantificationNiels Pallisgaard, Karen-Lise Garm Spindler, Rikke Fredslund Andersen, et al.
Pharmacological Research|January 15, 2019
Delta tocotrienol in recurrent ovarian cancer. A phase II trialCaroline Brenner Thomsen, Rikke Fredslund Andersen, Karina Dahl Steffensen, et al.
Scientific Reports|May 26, 2017
Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumabTorben Frøstrup Hansen, Rikke Fredslund Andersen, Dorte Aalund Olsen, et al.
Pageof 7